CLX vs PRLD · P/E 15, rev $7.10B vs rev $6.5M
The Clorox Company (CLX) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the CLX and PRLD stock pages for the full models.
Not investment advice.